The goal of the NIDA Clinical Trials Network and Addiction Technology Transfer Center (ATTC) webinar series is to help scholars and clinicians in the addiction field stay abreast of cutting edge science.

In this session, Larissa Mooney, MD, one of two PIs for the Greater Southern California Node of the NIDA Clinical Trials Network, will discuss recent trends in co-occurring methamphetamine use and opioid use disorder (OUD), including overdose fatalities. Participants will also learn about the treatment approaches to address this rising comorbidity.

Learning objectives

1. Recall at least two recent epidemiological trends in co-occurring methamphetamine use and opioid use disorder.
2. Identify at least three medical risks of co-occurring methamphetamine and opioid use.
3. Explain at least three evidence-based treatment approaches that can be utilized with patients who use both methamphetamine and opioids.

1.5 CME or CE credits available: AMA PRA Category 1 CreditsTM; PSY (APA); RN (CA BRN); LMFT, LCSW, LPCC, LEP (CAMFT); RADT I/II, CADC-CAS, CADC I/II, CADC-CS, LAADC (CCAPP); CATC (ACCBC/CAADE); CAODC (CADTP)

Please note: You must select the type of credits you would like to receive on the registration form; this information cannot be modified later. Zoom will track your attendance automatically; only those who attend the complete (live) event will be awarded credits (no partial credits available).

Sponsored by the Northwest and Pacific Southwest Addiction Technology Transfer Centers (ATTCs) and the Western States Node of the NIDA Clinical Trials Network.

Download flyer (includes information about CME and CE accreditation)